BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production
RRPV-26-10-RAPID The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Project Proposals (RPP) to stand up U.S.-based rapid antibody and protein binder production platforms that can go from pathogen gene sequence to immunoassay-ready reagents within weeks instead of months. This is a targeted opportunity to position platform […]
BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production Read More »